drug
dextromethorphan
Marketedupdated 6mo agoby Moberg Pharma AB
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval8 co-mentions · 3 sources
- drugPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE7 co-mentions · 2 sources
- tagRecall6 co-mentions · 5 sources
- drugguaifenesin6 co-mentions · 5 sources
- drugguaifenesin ER6 co-mentions · 5 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN4 co-mentions · 1 sources
- drugphenylephrine4 co-mentions · 1 sources
- tagSmall Molecule4 co-mentions · 3 sources
all catalysts(0)
nothing on the calendar yet
Trials studying dextromethorphan
- phase2Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
- phase1An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
- phase1A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
- phase2Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder
- phase3An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study
- phase2Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
- phase1A Study of Imlunestrant (LY3484356) in Female Healthy Participants
- phase3A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation
News(1)
- Fierce Biotech Fundraising Tracker '26: China's Eli Radiopharma raises $60M; Neurosterix notches $105MThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 10mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that